Maravai Lifesciences Holdings (MRVI) Change in Account Payables (2020 - 2026)

Maravai Lifesciences Holdings' Change in Account Payables history runs 7 years deep, the most recent figure standing at $6.2 million for Q1 2026.

• On a quarterly basis, Change in Account Payables rose 970.34% year-over-year to $6.2 million in Q1 2026; TTM through Mar 2026 was -$477000.0, a 112.9% decrease from a year earlier, with the FY2025 full-year figure at -$7.3 million, down 1116.18% from the prior year.
• Change in Account Payables rose to $6.2 million in Q1 2026 per MRVI's latest filing, from -$5.5 million in the prior quarter.
• Across five years, Change in Account Payables topped out at $6.2 million in Q1 2026 and bottomed at -$5.5 million in Q4 2025.
• The 5-year median for Change in Account Payables is $1.7 million (2023), against an average of $190823.5.
• Across the five-year window, Change in Account Payables plunged 1466.81% in 2024 and surged 970.34% in 2026, its largest moves.
• Year by year, Change in Account Payables stood at -$3.5 million in 2022, then soared by 147.84% to $1.7 million in 2023, then soared by 35.86% to $2.3 million in 2024, then slumped by 344.68% to -$5.5 million in 2025, then surged by 211.73% to $6.2 million in 2026.
• Per Business Quant, the three latest MRVI Change in Account Payables figures stand at $6.2 million (Q1 2026), -$5.5 million (Q4 2025), and -$2.9 million (Q3 2025).